MedTrace Logo

Study of Endostar Combined With TP Regimen for Esophageal Cancer

NCT04164797 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 402

Last updated 2019-11-25

No results posted yet for this study

Summary

a randomized controlled trial of endostar combined with TP regimen(liposomal paclitaxel-carboplatin) for chemoradiotherapy in esophageal squamous cell carcinoma(Ⅱ-Ⅲ)

Conditions

  • Patients With Esophageal Cancer(Ⅱ-Ⅲ)

Interventions

DRUG

endostar+chemoradiotherapy

antiangiogenic drug+chemoradiotherapy

OTHER

chemoradiotherapy

chemoradiotherapy

Sponsors & Collaborators

  • Second Affiliated Hospital of Xi'an Jiaotong University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-25
Primary Completion
2021-07-13
Completion
2021-07-13

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04164797 on ClinicalTrials.gov